In contrast to CEA, the sensitivity and specificity of serum HMGB1 levels for the diagnosis of cancer (EGC) was 67% and 71% (cut-off value of 5.5 ng/ml), and 71% and 67% (cut-off value of 5 ng/ml). This evidence concerns the gene HMGB1 and cancer.